Cargando…

Novel three-lncRNA signature predicts survival in patients with pancreatic cancer

A growing body of evidence confirms that long non-coding RNAs (lncRNAs) have an important role in biological processes by regulating gene expression at multiple levels. Dysregulated lncRNAs may be potential prognostic biomarkers or targets for the development of cancer treatments. However, the progn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Bin, Wang, Kaixuan, Fei, Janguo, Bao, Yi, Wang, Xiaoguang, Song, Zhengwei, Chen, Fei, Gao, Jun, Zhong, Zhengxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196600/ https://www.ncbi.nlm.nih.gov/pubmed/30542694 http://dx.doi.org/10.3892/or.2018.6761

Ejemplares similares

LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma
por: Li, Jiagen, et al.
Publicado: (2014)

Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma
por: Shi, Xiuhui, et al.
Publicado: (2018)

A Panel of 12-lncRNA Signature Predicts Survival of Pancreatic Adenocarcinoma
por: Zhang, Huo, et al.
Publicado: (2019)

LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer
por: Song, Zhengwei, et al.
Publicado: (2022)

A Signature of Nine lncRNA Methylated Genes Predicts Survival in Patients With Glioma
por: Cheng, Meng, et al.
Publicado: (2021)

The LncRNA Connectivity Map: Using LncRNA Signatures to Connect Small Molecules, LncRNAs, and Diseases
por: Yang, Haixiu, et al.
Publicado: (2017)

An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma
por: Qi, Bing, et al.
Publicado: (2021)

An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma
por: Huang, Xueyuan, et al.
Publicado: (2023)

Novel m7G-related lncRNA signature for predicting overall survival in patients with gastric cancer
por: Zhao, Bin, et al.
Publicado: (2023)

Development of epithelial-mesenchymal transition-related lncRNA signature for predicting survival and immune microenvironment in pancreatic cancerwithexperiment validation
por: Gao, Yong, et al.
Publicado: (2021)

A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma
por: Zhou, Meng, et al.
Publicado: (2018)

A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC)
por: Wang, Peng, et al.
Publicado: (2018)

A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma
por: Huang, Guo-Wei, et al.
Publicado: (2018)

An integrated mRNA–lncRNA signature for overall survival prediction in cholangiocarcinoma
por: Xu, Derong, et al.
Publicado: (2023)

A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma
por: Bao, Zhenyu, et al.
Publicado: (2017)

A seven-lncRNA signature for predicting Ewing’s sarcoma
por: Chen, Zhihui, et al.
Publicado: (2021)

A Hypoxia-Related lncRNA Signature Correlates with Survival and Tumor Microenvironment in Colorectal Cancer
por: Zhong, Xinyang, et al.
Publicado: (2022)

A novel lncRNA-mRNA-miRNA signature predicts recurrence and disease-free survival in cervical cancer
por: Li, Mengxiong, et al.
Publicado: (2021)

Clinical prognostic value of circulating tumor cells in the treatment of pancreatic cancer with gemcitabine chemotherapy
por: Wang, Xiaoguang, et al.
Publicado: (2021)

Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2022)

A three-lncRNA signature for prognosis prediction of acute myeloid leukemia in patients
por: Wang, Fangce, et al.
Publicado: (2018)

LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas
por: Wang, Wen, et al.
Publicado: (2016)

A prospective prognostic signature for pancreatic adenocarcinoma based on ubiquitination-related mRNA-lncRNA with experimental validation in vitro and vivo
por: Wang, Zhizhou, et al.
Publicado: (2023)

Identification of Circulating lncRNA Expression Profiles in Patients with Atrial Fibrillation
por: Ruan, Zhong-bao, et al.
Publicado: (2020)

Emodin inhibits the progression of acute pancreatitis via regulation of lncRNA TUG1 and exosomal lncRNA TUG1
por: Wen, Xiumei, et al.
Publicado: (2021)

LncRNA Profile Study Reveals a Three-LncRNA Signature Associated With the Pathological Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer
por: Zeng, Ying, et al.
Publicado: (2019)

Identification and characterization of the lncRNA signature associated with overall survival in patients with neuroblastoma
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2019)

The lncRNA Signatures of Genome Instability to Predict Survival in Patients with Renal Cancer
por: Huang, Liang, et al.
Publicado: (2021)

Necroptosis-related lncRNA signatures determine prognosis in breast cancer patients
por: Zhang, Yuan, et al.
Publicado: (2022)

Development and validation of a novel ferroptosis‑related lncRNA prognostic signature for pancreatic adenocarcinoma
por: Li, Jian, et al.
Publicado: (2023)

A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma
por: Zou, Wenbo, et al.
Publicado: (2021)

Comprehensive analyses of correlation and survival reveal informative lncRNA prognostic signatures in colon cancer
por: Gao, Meihong, et al.
Publicado: (2021)

Identification of a lncRNA based signature for pancreatic cancer survival to predict immune landscape and potential therapeutic drugs
por: Ma, Di, et al.
Publicado: (2022)

Identification of an Iron Metabolism-Related lncRNA Signature for Predicting Osteosarcoma Survival and Immune Landscape
por: Hong-bin, Shao, et al.
Publicado: (2022)

Identification and Validation of an Immune-Related lncRNA Signature to Facilitate Survival Prediction in Gastric Cancer
por: Ma, Ensi, et al.
Publicado: (2021)

AMP-activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas
por: Xu, Haokai, et al.
Publicado: (2020)

Identification of prognostic immune-related lncRNA signature predicting the overall survival for colorectal cancer
por: Li, Jianxin, et al.
Publicado: (2023)

Identification of a Glycolysis-Related LncRNA Signature to Predict Survival in Diffuse Glioma Patients
por: Wang, Yangyang, et al.
Publicado: (2021)

Signature of m5C-Related lncRNA for Prognostic Prediction and Immune Responses in Pancreatic Cancer
por: Liu, Xiangrong, et al.
Publicado: (2022)

Immunoautophagy-Related Long Noncoding RNA (IAR-lncRNA) Signature Predicts Survival in Hepatocellular Carcinoma
por: Wang, Yulu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_29ui75b4d29gr48hmdvs3bvv82